Document Detail


Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.
MedLine Citation:
PMID:  23059768     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Minimally invasive diagnostic tests are needed in obstetrics to identify women at risk for complications during delivery. The apolipoproteins fluctuate in complexity and abundance in maternal plasma during pregnancy and could be incorporated into a blood test to evaluate this risk. The objective of this study was to examine the relative plasma concentrations of apolipoproteins and their biochemically modified subtypes (i.e. proteolytically processed, sialylated, cysteinylated, dimerized) over gestational time using a targeted mass spectrometry approach. Relative abundance of modified and unmodified apolipoproteins A-I, A-II, C-I, C-II, and C-III was determined by surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in plasma prospectively collected from 11 gravidas with uncomplicated pregnancies at 4-5 gestational time points per patient. Apolipoproteins were readily identifiable by spectral pattern. Apo C-III(2) and Apo C-III(1) (doubly and singly sialylated Apo C-III subtypes) increased with gestational age (r(2)>0.8). Unmodified Apo A-II, Apo C-I, and Apo C-III(0) showed no correlation (r(2) = 0.01-0.1). Pro-Apo C-II did not increase significantly until third trimester (140 ± 13% of first trimester), but proteolytically cleaved, mature Apo C-II increased in late pregnancy (702 ± 130% of first trimester). Mature Apo C-II represented 6.7 ± 0.9% of total Apo C-II in early gestation and increased to 33 ± 4.5% in third trimester. A label-free, semiquantitative targeted proteomics approach was developed using LTQ-Orbitrap mass spectrometry to confirm the relative quantitative differences observed by surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in Apo C-III and Apo C-II isoforms between first and third trimesters. Targeted apolipoprotein screening was applied to a cohort of term and preterm patients. Modified Apo A-II isoforms were significantly elevated in plasma from mothers who delivered prematurely relative to term controls (p = 0.02). These results support a role for targeted proteomics profiling approaches in monitoring healthy pregnancies and assessing risk of adverse obstetric outcomes.
Authors:
Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Related Documents :
22861158 - Surgical treatment of ectopic pregnancy associated with predisposing factors of tuboper...
12533398 - Estrogen synthesis in fetal sheep brain: effect of maternal treatment with an aromatase...
17955188 - Effect of hormonal status and metabolic changes of restricted ewes during late pregnanc...
3047418 - Radio ultrasound observations of the fetotoxic effects in sheep from ingestion of coniu...
10459458 - Herpes simplex genitalis type 2: our experiences.
17434508 - Reassessing the value of varicocelectomy as a treatment for male subfertility with a ne...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-10-10
Journal Detail:
Title:  Molecular & cellular proteomics : MCP     Volume:  12     ISSN:  1535-9484     ISO Abbreviation:  Mol. Cell Proteomics     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-31     Completed Date:  2013-06-24     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  101125647     Medline TA:  Mol Cell Proteomics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  55-64     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoprotein A-II / blood
Apolipoprotein C-I / blood
Apolipoprotein C-II / blood
Apolipoprotein C-III / blood
Apolipoproteins / blood*
Biological Markers / blood
Female
Gestational Age*
Humans
Longitudinal Studies
Mass Spectrometry
Pregnancy
Pregnancy Outcome*
Proteomics
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Chemical
Reg. No./Substance:
0/Apolipoprotein A-II; 0/Apolipoprotein C-I; 0/Apolipoprotein C-II; 0/Apolipoprotein C-III; 0/Apolipoproteins; 0/Biological Markers
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Facile synthesis of the pentasaccharide repeating unit of the cell wall O-antigen of Escherichia col...
Next Document:  Cardiopulmonary Variables During Exercise Predict Pregnancy Outcome in Women With Congenital Heart D...